Limited Competition: Renewal of Centers of Biomedical Research Excellence (COBRE) (Phase 2) (P20 - Clinical Trial Optional)
0 Saves · 0 Shares · 1 Comments Discussion
Related opportunities
- Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science for UM1 CTSA Hub Awards (RC2 Clinical Trials Not Allowed)
- Health Sep 13, 2024 12:00:00 AM EDT $500,000
- NIOSH Centers for Agricultural Safety and Health
- Health Dec 01, 2024 12:00:00 AM EST $2,200,000
- Enhancing Science, Technology, EnginEering, and Math Educational Diversity (ESTEEMED) Research Education Experiences (R25 Clinical Trial Not Allowed)
- Health Jan 17, 2025 12:00:00 AM EST $325,000
- Industrialization and Translation of Extracellular Vesicles for use in Regenerative Medicine (U43/U44 Clinical Trials Not Allowed)
- Health Jun 06, 2025 12:00:00 AM EDT $295,924
- Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional)
- Health Sep 05, 2025 12:00:00 AM EDT $1,838,436
- Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional)
- Health Sep 05, 2025 12:00:00 AM EDT $1,838,436
- MOMENTUM (Moving integrated, quality Maternal, Newborn, and Child Health and Family Planning and Reproductive Health services to scale): Targeted MNCH/FP/RH technical assistance to private providers
- Medicine September 30, 2025 Up to 75,000,000 USD
- MOMENTUM (Moving Integrated, Quality Maternal, Newborn, and Child Health and Family Planning and Reproductive Health Services to Scale)
- Medicine September 30, 2025 Up to 25,000,000 USD
- MRFF 2022 Frontier Health and Medical Research Grant Opportunity
- Health and Medical Research 31-Mar-2026 $400,000,000.00